Hypoactive sexual desire disorder. Hypoactive sexual desire disorder
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Postmenopausal women between the ages of 40 and 65, who have been for a year since their last period, and complain of decreased sexual desire Completing the FSFI questionnaire and assessing the loss of sexual desire based on it, including a number equal to or less than 26 Menopause symptoms are not severe (less than 5), the score of the MSR questionnaire (menopause symptom severity) is 1 to 5 Having an emotionally satisfying relationship with a stable and sexually active spouse for at least the last 6 months Normal pelvic examination Having a wife who spends at least half of a month with the family At least 6 months have passed since the beginning of cohabitation Signing consent to participate in the project
Exclusion criteria
Exclusion criteria: Vaginal infection Vaginal bleeding The presence of a serious physical medical condition and a chronic illness that requires constant care Taking any chemical and herbal medicine known to affect libido Smoking and any substance abuse Disruption of a satisfactory emotional relationship with the spouse during the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sexual desire. Timepoint: At first, 2 week, 4week. Method of measurement: FSFI questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sexual arousal levels. Timepoint: At first, 2week, 4week. Method of measurement: FSFI questionnaire.;Vaginal lubrication levels. Timepoint: At first, 2 week ,4 week. Method of measurement: FSFI questionnaire.;Orgasm levels. Timepoint: At first, 2week ,4week. Method of measurement: FSFI questionnaire.;Satisfaction sexual levels. Timepoint: At first, 2week, 4week. Method of measurement: FSFI questionnaire.;Disparonia levels. Timepoint: At first, 2week, 4week. Method of measurement: FSFI questionnaire.;Sexual function. Timepoint: At first, 2week, 4week. Method of measurement: FSFI questionnaire.;Side effects of drugs. Timepoint: 2week and 4 week. Method of measurement: Medication side effects questionnaire.;BoBody temperament. Timepoint: At first and the end of study( after 4 weeks). Method of measurement: Body temperament questionnaire.;Severity of menopause symptom. Timepoint: At first and the end of study. Method of measurement: MSR questionnaire.;Severity of menopause. Timepoint: At first and end of study. Method of measurement: Menopause Rating Scale (MRS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Iran University of Medical Sciences